Literature DB >> 22274565

Estrogenic modulation of inflammation-related genes in male rats following volume overload.

Jennifer L McLarty1, Giselle C Meléndez, Scott P Levick, Shanté Bennett, Tara Sabo-Attwood, Gregory L Brower, Joseph S Janicki.   

Abstract

Our laboratory has previously reported significant increases of the proinflammatory cytokine TNF-α in male hearts secondary to sustained volume overload. These elevated levels of TNF-α are accompanied by left ventricular (LV) dilatation and cardiac dysfunction. In contrast, estrogen has been shown to protect against this adverse cardiac remodeling in both female and male rats. The purpose of this study was to determine whether estrogen has an effect on inflammation-related genes that contribute to this estrogen-mediated cardioprotection. Myocardial volume overload was induced by aortocaval fistula in 8 wk old male Sprague-Dawley rats (n = 30), and genes of interest were identified using an inflammatory PCR array in Sham, Fistula, and Fistula + Estrogen-treated (0.02 mg/kg per day beginning 2 wk prior to fistula) groups. A total of 55 inflammatory genes were modified (≥2-fold change) at 3 days postfistula. The number of inflammatory gene was reduced to 21 genes by estrogen treatment, whereas 13 genes were comparably modulated in both fistula groups. The most notable were TNF-α, which was downregulated by estrogen, and the TNF-α receptors, which were differentially regulated by estrogen. Specific genes related to arachidonic acid metabolism were downregulated by estrogen, including cyclooxygenase-1 and -2. Finally, gene expression for the β1-integrin cell adhesion subunit was significantly upregulated in the LV of estrogen-treated animals. Protein levels reflected the changes observed at the gene level. These data suggest that estrogen provides its cardioprotective effects, at least in part, via genomic modulation of numerous inflammation-related genes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22274565      PMCID: PMC3327141          DOI: 10.1152/physiolgenomics.00146.2011

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  41 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Impact of aging vs. estrogen loss on cardiac gene expression: estrogen replacement and inflammation.

Authors:  Angela S Pechenino; Li Lin; Fiona N Mbai; Alison R Lee; Xian-Min He; John N Stallone; A A Knowlton
Journal:  Physiol Genomics       Date:  2011-07-12       Impact factor: 3.107

3.  Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators.

Authors:  J An; R C Ribeiro; P Webb; J A Gustafsson; P J Kushner; J D Baxter; D C Leitman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

4.  Secretory type II phospholipase A(2) binds to ischemic myocardium during myocardial infarction in humans.

Authors:  Remco Nijmeijer; Wim K Lagrand; Alexi Baidoshvili; Yvonne T P Lubbers; Wim Th Hermens; Chris J L M Meijer; Cees A Visser; C Erik Hack; Hans W M Niessen
Journal:  Cardiovasc Res       Date:  2002-01       Impact factor: 10.787

Review 5.  Prostaglandins and leukotrienes: advances in eicosanoid biology.

Authors:  C D Funk
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

6.  Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure.

Authors:  B Bozkurt; G Torre-Amione; M S Warren; J Whitmore; O Z Soran; A M Feldman; D L Mann
Journal:  Circulation       Date:  2001-02-27       Impact factor: 29.690

7.  Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression.

Authors:  T Kadokami; C F McTiernan; T Kubota; C S Frye; A M Feldman
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

8.  Gender differences in cardiac remodeling secondary to chronic volume overload.

Authors:  Jason D Gardner; Gregory L Brower; Joseph S Janicki
Journal:  J Card Fail       Date:  2002-04       Impact factor: 5.712

9.  Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity.

Authors:  Gregory L Brower; Amanda L Chancey; Srihari Thanigaraj; Beatriz B Matsubara; Joseph S Janicki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-08       Impact factor: 4.733

10.  Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARgamma : Possible relevance to human fibrotic disorders.

Authors:  Mónica B Frungieri; Stephan Weidinger; Viktor Meineke; Frank M Köhn; Artur Mayerhofer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-23       Impact factor: 11.205

View more
  4 in total

1.  Estrogen inhibits mast cell chymase release to prevent pressure overload-induced adverse cardiac remodeling.

Authors:  Jianping Li; Shaiban Jubair; Joseph S Janicki
Journal:  Hypertension       Date:  2014-11-17       Impact factor: 10.190

2.  Estrogen receptor antagonism exacerbates cardiac structural and functional remodeling in female rats.

Authors:  M C El Hajj; V K Ninh; E C El Hajj; J M Bradley; J D Gardner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-10-21       Impact factor: 4.733

3.  Temporal changes in integrin-mediated cardiomyocyte adhesion secondary to chronic cardiac volume overload in rats.

Authors:  James A Stewart; Jason D Gardner; Gregory L Brower; Joseph S Janicki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-25       Impact factor: 4.733

4.  Estrogen modulates the influence of cardiac inflammatory cells on function of cardiac fibroblasts.

Authors:  Jennifer L McLarty; Jianping Li; Scott P Levick; Joseph S Janicki
Journal:  J Inflamm Res       Date:  2013-08-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.